12/12/2022 8:38:06 AM
CSL Seqirus Finalizes Global Collaboration And License Agreement With Arcturus Therapeutics Holdings
9/26/2022 8:05:07 AM
CSL Says Data Shows Cell-Based And MF59-Adjuvanted Influenza Vaccines Reduce Burden Of Seasonal Influenza On Hospitals
7/13/2022 1:09:13 AM
CSL Announces Postponement Of Settlement Of Vifor Pharma Tender Offer Until September 30, 2022
12/14/2021 12:50:39 AM
CSL To Acquire Vifor Pharma For Aggregate Equity Value For Vifor Pharma Of $11.7/CHF 10.9 Bln
12/13/2021 12:04:32 AM
Australia's CSL Confirms Talks With Vifor Pharma Regarding Potential Acquisition